Pavmed Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pavmed Inc 's ROA in the second quarter of 2026?
Pavmed Inc recorded a cumulative net loss of $-16 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -40.37%.

However, within the Healthcare sector 491 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 3506 to 3962.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-4.9 %	-11.62 %	34.06 %	31.92 %	20.01 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-16	-22	-2	1	68
Return On Assets (TTM)	-40.37 %	-53.75 %	-5.78 %	3.55 %	179.6 %
PAVM's Total Ranking	# 3962	# 3506	# 1503	# 26	# 34
Total Assets (TTM) in million	41	45	39	38	43
Seq. Total Assets Change	-10.83 %	17.02 %	1.95 %	-10.61 %	-17.14 %
Seq. Net Income Change	-	-	-	-	-

PAVM's 5 Years Annual ROA >> Back to PAVM Management Effectiveness >> Compare PAVM ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 136
Sector	# 492
Overall	# 3761

Return On Assets Statistics
High	Average	Low
172.62 %	-216.78 %	-906.27 %
(Jun 30 2025)		(Sep 30 2017)

Financial Statements
Pavmed Inc 's Assets	$ 41 million	PAVM's Balance sheet
Pavmed Inc 's Income	$ -7 million	Quarterly PAVM's Income Statement
PAVM's Income by Division		See PAVM's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	151.91 %	-5.71 %	-40.75 %	-40.42 %	339.76 %
Total Assets in million	73	29	31	52	87
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-2	28	-79	-103	-56
Annual Return On Assets	-3.39 %	98.19 %	-258.14 %	-199.22 %	-64.53 %

PAVM's 5 Years Annual ROA >> Back to PAVM Management Effectiveness >> Compare PAVM ROA to its Competitors

More Return On Assets Ratios
PAVM's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PAVM's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PAVM's Competitors
Subscribers only: Roa for Pavmed Inc 's Suppliers
Subscribers only: Return On Assets for PAVM's Customers

You may also want to know
PAVM's Roi	PAVM's Inventory Turnover Ratio	PAVM's Growth Rates	PAVM's Dividend Comparisons
	PAVM's Profitability Ratios	PAVM's Asset Turnover Ratio	PAVM's Dividend Growth
PAVM's Roe	PAVM's Valuation Ratios	PAVM's Financial Strength Ratios	PAVM's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-03T12:06:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.